Today’s AI Top Pick: GPI

8/7/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

View the live GPI price forecast →

Today's pick · Low Float Bullish Consensus Deep RotationGPIBUY NOW8.6 / 108/7/2026

Group 1 Automotive is the only name in this pool that combines real, cash-generative fundamentals with a textbook 'pullback into support' tape setup — and that's exactly what the lens is asking for. Fundamentals: trailing PE 11.29, forward PE 6.15, PEG 0.87, ROE 9.4, profit margin 1.29, 99.08% institutional ownership, and an analyst consensus of 2.0 with 37.3% target upside. It is the only candidate here that is unambiguously profitable at scale ($3.23B cap) — most of the rest are sub-$50M biotech lottery tickets with negative margins. The tape confirms an entry TODAY, not later. On the 1d timeframe GPI sits at position 0.94% of its 21-bar range with a -24.12% drawdown from the 21-bar high, yet the 1d forecast is +20.71 / +36.02 / +44.08 (short/mid/long) with bullish_prob = 1 and near_term_bullish = 1. The 4h corroborates: pos 2.9% in range, dd -9.17%, forecasts +22.5 / +30.29 / +35.04. Both intraday and daily horizons agree that a rip is set up from a washed-out base — this is the exact 'bottom of range + strong forward forecast' profile the lens rewards. The 1wk is the one soft spot (fc_short +0.42, fc_mid -6.14, fc_long +7.16), which is why this is a swing-trade entry, not a multi-quarter hold. Higher-scoring MORN is at position 89-100% of its 21-bar range across every timeframe with a -14.52% weekly recent move being POSITIVE (i.e., it's ripping) and 4h forecast NEGATIVE (-8.09%). That is chasing the top, exactly what the rules say to avoid. ANNA has decent fundamentals but tiny float, no analyst target, and 1wk forecasts of +300%+ that look like a single-bar outlier. USNA, USBC, LBRDA, MORN, DRMA, COSM all fail one of: at top of range, dilution headline, or -100% weekly forecast. USNA specifically has a Q2 loss + guidance cut + rating downgrade in the last 48 hours — hard pass despite passing the screen. The news check: JPM lowered its PT to $275 (still Neutral, essentially at current price) and Evercore ISI lowered but held Outperform at $360 (+32.5% from spot). Those are trims, not thesis-breakers, and they align with the tape's washout. Buying at $271.64 with two analysts still positive, 37.3% consensus upside, and every intraday/daily forecast pointing higher is a favorable asymmetry.

GPI forecast chart
Entry zone
$268-$275 (scale in; current $271.64 is in-zone, add on any dip toward $265)
Stop loss
$249 (below the 21-bar low, roughly -8.5% from entry; invalidates the base)
First target
$305-$315 (aligns with 4h fc_short +22.5% and 1d fc_short +20.7%; ~12-16% move)
Longer target
$355-$372 (Evercore PT $360 and 1d fc_long +44% zone; 30-37% swing target)
Risks
  • Weekly forecast is soft (1wk fc_mid -6.14%) — if the bounce fails, the larger trend is still down and the -36% YoY / -31% YTD keeps working
  • Debt/Equity of 1.96 is elevated for a cyclical auto retailer; a rate re-acceleration (10Y toward 5% per broader tape) squeezes floor plan financing costs
  • Profit margin of only 1.29% means small revenue misses become large EPS misses; salesYoY of just 0.81% is anemic
  • Two sell-side price target CUTS this week (JPM to $275, Evercore to $360) — momentum in analyst revisions is still negative even if ratings held
  • RSI 36.03 can bleed lower before reversing; catching a falling knife on a stock down 36% in a year requires respecting the stop
Honorable mentions
ANNAOnly other name with genuine profitability (PE 17.55, ROE 17.97, profit margin 17.43, oper margin 30.31). Sitting at 0% of 21-bar range on 1d with -31.35% drawdown, near_term_bullish=1, positive SeekingAlpha coverage on Italian gas revival thesis. Downgraded to #2 vs GPI because float is tiny, no analyst target/consensus, and 1wk forecasts of +300%+ look like a low-sample outlier.
GLMDMicro-cap biotech but the tape is clean: near_term_bullish=1, bullish_prob=1, 4h and 1d both near mid-range (not top), 1d forecast +11/+47/+95 with two positive pipeline catalysts in the last 3 weeks (Parkinson's ODF, cardiac LNP). No dilution headlines. Purely speculative but a legit tier-3 lottery ticket with catalyst flow.
Full ranking (30)
#SymbolVerdictScoreRead
1GPIBUY NOW8.6Profitable, cheap (fwdPE 6.15), bottom of 21-bar range, bullish_prob=1, forecasts +20-44% across 4h/1d — best risk/reward today.
2ANNABUY NOW7.2Real earnings (ROE 17.97, margin 17.43), washed out at 0% of range, positive SA thesis on Italian gas — the tier-2 fundamental play.
3GLMDBUY NOW6.6Clean multi-TF alignment, near_term_bullish=1, back-to-back positive pipeline catalysts, no dilution overhang.
4IDNBUY NOW6.4Profitable tech micro-cap (margin 9.56, gross 90.68), 4h pos 1.84%, forecasts +25-64%, though 1wk still weak.
5QNTMBUY NOW6.0Near_term_bullish=1, 4h forecast +73-96%, debt settlement closed, Lucid-MS narrative intact.
6PRSOBUY NOW5.9Near_term_bullish=1 with 4h/1d forecasts +25-47%, no dilution news, but salesYoY -40.57% is a red flag.
7MORNBUY PULLBACK5.8Best fundamentals in pool (ROE 32, PEG 0.76) but stretched at 89-100% of range and 4h forecast is negative — chase risk.
8BCDABUY NOW5.71d at 100% of range but 4h forecast +28% and 1wk +145% suggest breakout continuation; shortFloat 13.17 adds squeeze fuel.
9INDPBUY NOW5.6RSI 30.07 oversold, near_term_bullish=1, forecasts +58/+133/+239 on 1d — deep-value bounce candidate.
10LTRNBUY NOW5.5Legitimate positive catalyst (EMA clearance, Open-Medicine AI spinoff), near_term_bullish=0.6, 4h forecast modest.
11INTZBUY NOW5.3Near_term_bullish=1 with 4h/1d forecasts +21-68% and no negative headlines; 1wk forecast negative is the caveat.
12LUCYBUY NOW5.2Near_term_bullish=1, 1d forecast +21-112%, positive Claude AI integration catalyst, but recent warrant exercise adds float.
13CNCKWAIT5.0Earnings beat but 56M-share resale prospectus filed July 31 = supply overhang; 4h forecast slightly negative.
14GRCEBUY PULLBACK4.8Positive FDA news but $10M private placement announced Aug 5 — take the dilution dip.
15DRMAWAIT4.71wk forecast +14,433% is a broken outlier; 4h looks fine but too speculative to size around.
16XTLBBUY PULLBACK4.6All three timeframes forecast up (+7-100%), but recent_21bar +16-22% means it's already extended.
17EVGNBUY PULLBACK4.5Real pipeline catalysts (PCSK9, agritech), but recent_21bar +57% on 4h and near_term_bullish only 0.2 — wait for reset.
18DAREBUY PULLBACK4.4Earnings on Aug 13 is a binary event; 4h/1d forecasts strong but debtEq 9.84 is scary.
19NXLWAIT4.2Near_term_bullish=1 but operMargin -3084% and grossMargin -664% make this uninvestable size.
20HCWBAVOID4.1Just-announced $1.6M private placement at $2.5849 = fresh dilution below current $3.50.
21TNXPWAIT4.0Near_term_bullish=0 despite positive FDA/coverage headlines; 1d forecast slightly negative.
22YCBDWAIT3.9Bullish_prob only 0.6, no timeframe alignment, only near_term_bullish 0.6.
23AKTXAVOID3.81wk forecast -72.92% across all horizons and near_term_bullish 0.2 — Maxim upgrade doesn't offset.
24RGNTWAIT3.7Bullish_prob null, only 1d timeframe available, -70.77% YTD — no consensus signal.
25LBRDAAVOID3.6Sitting at 100% of range on 4h AND 1d — pure chase; RSI 68.57 confirms overbought.
26COSMAVOID3.51wk forecast is -100% across all horizons — model has ejected this name.
27NXTCAVOID3.2$320M private placement plus reverse-merger with Avere makes the old NXTC thesis moot.
28IPWRAVOID3.0Filed $75M shelf prospectus July 10; ps 2337, operMargin -45,871% — dilution + no business economics.
29USBCAVOID2.8Near_term_bullish=0, 1d forecast -37 to -48%, 11,328% analyst target is a data error.
30USNAAVOID2.4Lowered guidance + Q2 loss + explicit rating downgrade in last 48h — screen thesis is broken by the news.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.